Medicare, with little public debate,  has expanded its reimbursement for unapproved uses of cancer drugs, the New York Times reports this morning.
The latest cancer drugs can cost tens of thousands of dollars per patient. Medicare spends more than $3 billion a year on cancer drugs, and private insurers, who pay for most of the rest [...]

Employee health-insurance premiums rose another 5% this year, says a widely watched annual survey published today. That’s a milder increase than those seen a few years back.
Overall, families are paying an average of $12,680 per year in premiums. But dig a little deeper into the report and it becomes clear that there’s really wide variation [...]